Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Lobe Sciences Announces Filing of PCT Application

Lobe Sciences Announces Filing of PCT Application

  • Post published:April 29, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use

  • Post published:April 27, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

Lobe Sciences Appoints Benjamin Kelmendi, MD from Yale University to Scientific Advisory Board

  • Post published:April 20, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Appoints Ilan Hayman to Advisory Board

Lobe Sciences Appoints Ilan Hayman to Advisory Board

  • Post published:April 6, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Becomes Enterprise Member of NFL Alumni Association

Lobe Sciences Becomes Enterprise Member of NFL Alumni Association

  • Post published:March 31, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands

Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands

  • Post published:March 8, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

  • Post published:March 3, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

  • Post published:February 23, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

  • Post published:February 18, 2021
  • Post category:Press Release
Read more about the article Lobe Sciences Announces Management Changes and New Director

Lobe Sciences Announces Management Changes and New Director

  • Post published:January 18, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More